Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of pet food; sales of food additives; and raw materials. In addition, the company provides chlortetracycline, oxytetracycline, and other formulations. The company was founded in 1990 and is headquartered in Hohhot, China.
Research context
Jinhe Biotechnology CO., LTD appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
Jinhe Biotechnology CO., LTD is currently in a long term uptrend where the price is trading 9.0% above its 200 day moving average.
From a valuation standpoint, the stock is 78.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Jinhe Biotechnology CO., LTD's total revenue rose by 13.8% to $608M since the same quarter in the previous year.
Its net income has dropped by 63.1% to $15M since the same quarter in the previous year.
Finally, its free cash flow grew by 1203.4% to $23M since the same quarter in the previous year.
Based on the above factors, Jinhe Biotechnology CO., LTD gets an overall score of 4/5.